ANDA 200674, held by Fresenius Kabi USA. Levofloxacin.
As of Nov 16, 2026, ANDA 200674 (Levofloxacin In Dextrose 5% In Plastic Container), held by Fresenius Kabi USA, was first approved by FDA on Jun 19, 2013, with 6 approved supplements and 0 published complete response letters.
Levofloxacin in 5% Dextrose Injection is indicated for the treatment of adults (≥ 18 years of age) with mild, moderate, and severe infections caused by susceptible isolates of the designated microorganisms in the conditions listed in this section. Levofloxacin in 5% Dextrose Injection is indicated when intravenous administration offers a route of administration advantageous to the patient (e.g., patient cannot tolerate an oral dosage form). Levofloxacin in 5% Dextrose Injection is a fluoroquinolone antibacterial indicated in adults (≥ 18 years of age) with infections caused by designated, susceptible bacteria ( 1, 12.4 ).
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 19, 2013 | Original application | Approved | None posted |
| Levofloxacin In Dextrose 5% In Plastic ContainerEQ 250MG/50ML (EQ 5MG/ML) · injectable;injection | Levofloxacin | Rx |
| Levofloxacin In Dextrose 5% In Plastic ContainerEQ 500MG/100ML (EQ 5MG/ML) · injectable;injection | Levofloxacin | Rx |
| Levofloxacin In Dextrose 5% In Plastic ContainerEQ 750MG/150ML (EQ 5MG/ML) · injectable;injection | Levofloxacin | Rx |
| Sep 20, 2024 | Supplement 13Labeling · Standard review | Approved | None posted |
| May 3, 2019 | Supplement 8Labeling · Standard review | Approved | None posted |
| Apr 24, 2019 | Supplement 4Labeling · Standard review | Approved | None posted |
| Oct 18, 2018 | Supplement 6Labeling · Standard review | Approved | None posted |
| Oct 19, 2015 | Supplement 1Labeling · Standard review | Approved | None posted |
| Oct 19, 2015 | Supplement 3Labeling · Standard review | Approved | None posted |
| Jun 19, 2013 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters